Cryoport Systems · 1 day ago
Accounts Payable Specialist
Cryoport Systems is the life science industry’s most trusted provider of supply chain solutions for temperature-sensitive materials. The Accounts Payable Specialist will primarily focus on accounts payable, ensuring timely processing while also handling general accounting responsibilities such as journal entries and account reconciliations.
Clinical TrialsLogisticsShipping
Responsibilities
Review, code and enter all vendor bills/ invoices
Enter bills/ invoices with purchase order through the 3-way match
Monitor and ensure bills/ invoices are approved timely
Collect back up receipts and record credit card purchases
Prepare weekly check run file for the Controller review and approve
Process weekly check run and mail out or wire payments
Review and reconcile vendor statements against accounting records
Manage and respond to vendor inquires
Research and resolve any payable discrepancies
Maintain vendor files
Reconcile A/P subledger to ledger monthly
Provide administrative support and other projects as assigned
Assist to ensure an accurate and timely monthly, quarterly and year end close
Assist with schedules for SEC quarterly review and annual audits
Assist with SOX compliance
Respond to inquiries from the management, CFO and Controller, special reporting requests and the like
Assist with financial analysis reports, as needed
Make recommendations and assist in improving procedures
Must be available to work in the evenings and weekends, as needed
Qualification
Required
Associates degree
3-5 years accounting experience, including accounts payable experience
Proficiency in fair credit practices and accounting principles
Proficiency in MS Office including Intermediate to Advanced Excel skills
Preferred
Bachelor's degree in finance/accounting
Working knowledge of Sage 100 and Netsuite
Company
Cryoport Systems
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the Life Sciences industry.
Funding
Current Stage
Public CompanyTotal Funding
$1.11BKey Investors
Blackstone Group
2021-11-10Post Ipo Debt· $350M
2021-01-19Post Ipo Equity· $287.5M
2020-08-25Post Ipo Equity· $275M
Leadership Team
Recent News
BioTech Breakthrough
2025-11-08
BioTech Breakthrough
2025-11-07
Company data provided by crunchbase